Skip to content

Clinical trials

Phase 2 Lymphoma, Large B-Cell, Diffuse trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2 Country / region: Switzerland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20071
20152
20161
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Insel Gruppe AG, University Hospital Bern2
Celgene1
Children's Oncology Group1
Debiopharm International SA1
German High-Grade Non-Hodgkin's Lymphoma Study Group1
Lymphoma Study Association1
Oncology Institute of Southern Switzerland1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse11
Burkitt Lymphoma4
Lymphoma4
Lymphoma, Follicular4
Lymphoma, Mantle-Cell4
Lymphoma, Non-Hodgkin4
Dendritic Cell Sarcoma, Interdigitating3
Lymphoma, Large-Cell, Immunoblastic3
Breast Neoplasms2
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.